Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer

Cancer Research

Volumn 68, Issue 3, 2008, Pages 880-888

  Berndt, Uta ^a   Philipsen, Lars ^b   Bartsch, Sebastian ^b   Wiedenmann, Bertram ^a   Baumgart, Daniel C ^a   Hämmerle, Marcus ^b   Sturm, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MelTec GmbH and Co KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CASPASE 3; CASPASE 8; CD3 ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTEIN BAX;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER TISSUE; CD4+ CD25+ T LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; FEMALE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LAMINA PROPRIA; MALE; MEDICAL TECHNOLOGY; MULTIEPITOPE LIGAND CARTOGRAPHY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEOMICS; ROBOTICS; T LYMPHOCYTE ACTIVATION; TISSUE STRUCTURE; TUMOR IMMUNITY; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD18; CD4-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; HLA ANTIGENS; HUMANS; INTEGRIN ALPHA CHAINS; INTERCELLULAR ADHESION MOLECULE-1; INTESTINAL MUCOSA; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NEUTROPHILS; PROTEOMICS; T-LYMPHOCYTES;

EID: 38849085293     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2923     Document Type: Article

References (39)

1. Weitz J, Koch M, Debus J, et al. Colorectal cancer. Lancet 2005;365:153-65.
2. Evans C, Dalgleish AG, Kumar D. Review article: immune suppression and colorectal cancer. Aliment Pharmacol Ther 2006;24:1163-77.
3. Zhu H, Bilgin M, Snyder M. Proteomics. Annu Rev Biochem 2003;72:783-812.
4. Kok K, Stokkers P, Reitsma PH. Genomics and proteomics: implications for inflammatory bowel diseases. Inflamm Bowel Dis 2004;10 Suppl 1:S1-6.
5. Felley-Bosco E, Andre M. Proteomics and chronic inflammatory bowel diseases. Pathol Res Pract 2004;200:129-33.
6. Bonnekoh B, Pommer AJ, Bockelmann R, et al. Topoproteomic in situ analysis of psoriatic plaque under efalizumab treatment. Skin Pharmacol Physiol 2007;20:237-52.
7. Berndt U, Bartsch S, Philipsen L, et al. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis. J Immunol 2007;179:295-304.
8. Schubert W. Topological proteomics, toponomics, MELK-technology. Adv Biochem Eng Biotechnol 2003;83:189-209.
9. Schubert W, Bonnekoh B, Pommer AJ, et al. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat Biotechnol 2006;24:1270-8.
10. Schubert W. Cytomics in characterizing toponomes: towards the biological code of the cell. Cytometry A 2006;69:209-11.
11. Zeitz M, Schieferdecker HL, Ullrich R, et al. Phenotype and function of lamina propria T lymphocytes. Immunol Res 1991;10:199-206.
12. Schieferdecker HL, Ullrich R, Hirseland H, Zeitz M. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunol 1992;149:2816-22.
13. Clarke SL, Betts GJ, Plant A, et al. CD4CD25FOXP3 regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE 2006;1:e129.
14. Jackson PA, Green MA, Marks CG, et al. Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas. Gut 1996;38:85-9.
15. Li XW, Ding YQ, Cai JJ, et al. Studies on mechanism of Sialy Lewis-X antigen in liver metastases of human colorectal carcinoma. World J Gastroenterol 2001;7:425-30.
16. Kitayama J, Nagawa H, Nakayama H, et al. Functional expression of β1 and β2 integrins on tumor infiltrating lymphocytes (TILs) in colorectal cancer. J Gastroenterol 1999;34:327-33.
17. Wingren AG, Parra E, Varga M, et al. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol 1995;15:235-53.
18. Qiao L, Schurmann G, Betzler M, Meuer SC. Activation and signaling status of human lamina propria T lymphocytes. Gastroenterology 1991;101:1529-36.
19. Targan SR, Deem RL, Liu M, Wang S, Nel A. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol 1995;154:664-75.
20. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol 2004;22:405-29.
21. Tachibana T, Onodera H, Tsuruyama T, et al. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res 2005;11:7322-7.
22. Matera L, Galetto A, Bello M, et al. In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma. J Transl Med 2006;4:49.
23. Schubert P, Hoffman MD, Sniatynski MJ, Kast J. Advances in the analysis of dynamic protein complexes by proteomics and data processing. Anal Bioanal Chem 2006;386:482-93.
24. Karin M. NF-κB and cancer: mechanisms and targets. Mol Carcinog 2006;45:355-61.
25. Aggarwal BB. Nuclear factor-κB: the enemy within. Cancer Cell 2004;6:203-8.
26. Titu LV, Monson JR, Greenman J. The role of CD8(+) T cells in immune responses to colorectal cancer. Cancer Immunol Immunother 2002;51:235-47.
27. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455-8.
28. Ling KL, Pratap SE, Bates GJ, et al. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 2007;7:7.
29. Erdman SE, Poutahidis T, Tomczak M, et al. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003;162:691-702.
30. Viguier M, Lemaitre F, Verola O, et al. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 2004;173:1444-53.
31. Enarsson K, Lundin BS, Johnsson E, Brezicka T, Quiding-Jarbrink M. CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients. Eur J Immunol 2007;37:282-91.
32. Dalerba P, Maccalli C, Casati C, Castelli C, Parmiani G. Immunology and immunotherapy of colorectal cancer. Crit Rev Oncol Hematol 2003;46:33-57.
33. Matsushita K, Takenouchi T, Shimada H, et al. Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: possible involvement of c-myc suppression by interferon-γ in situ. Cancer Sci 2006;97:57-63.
34. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990;8:365-400.
35. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
36. Stallmach A, Giese T, Pfister K, et al. Activation of β(1) integrins mediates proliferation and inhibits apoptosis of intestinal CD4-positive lymphocytes. Eur J Immunol 2001;31:1228-38.
37. Sturm A, Krivacic KA, Fiocchi C, Levine AD. Dual function of the extracellular matrix: stimulatory for cell cycle progression of naive T cells and antiapoptotic for tissue-derived memory T cells. J Immunol 2004;173:3889-900.
38. Dippold W, Wittig B, Schwaeble W, Mayet W, Meyer zum Buschenfelde KH. Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. Gut 1993;34:1593-7.
39. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24-37.